Items where Author is "Junghanss, C."

Article

Knop, S. and Langer, C. and Engelhardt, M. and Muegge, L.-O. and Reichle, A. and Roesler, W. and Bassermann, F. and Hertenstein, B. and Kunitz, A. and Roellig, C. and Ostermann, H. and Schaefer-Eckart, K. and Ringhoffer, M. and Guenther, A. and Junghanss, C. and Biersack, H. and Schreder, M. and Liebert, A. and Held, S. and Einsele, H. and Bargou, R. C. (2017) Lenalidomide, adriamycin, dexamethasone for induction followed by stem-cell transplant in newly diagnosed myeloma. LEUKEMIA, 31 (8). pp. 1816-1819. ISSN 0887-6924, 1476-5551

Andree, H. and Hilgendorf, I. and Leithaeuser, M. and Junghanss, C. and Holzhueter, S. and Loddenkemper, C. and Steiner, B. and Freund, M. and Wolff, D. (2008) Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD. BONE MARROW TRANSPLANTATION, 42 (8). pp. 541-546. ISSN 0268-3369

Wolff, Daniel and Wilhelm, S. and Hahn, J. and Gentilini, C. and Hilgendorf, I. and Steiner, B. and Kahl, C. and Junghanss, C. and Hartung, G. and Casper, J. and Uharek, L. and Holler, E. and Freund, M. (2006) Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease. BONE MARROW TRANSPLANTATION, 38 (6). pp. 445-451. ISSN 0268-3369

Wolff, Daniel and Roessler, V. and Steiner, B. and Wilhelm, S. and Weirich, V. and Brenmoehl, Julia and Leithaeuser, M. and Hofmeister, N. and Junghanss, C. and Casper, J. and Hartung, G. and Holler, Ernst and Freund, M. (2005) Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept. BONE MARROW TRANSPLANTATION, 35 (10). pp. 1003-1010. ISSN 0268-3369, 1476-5365

Conference or Workshop Item

Stoelzel, F. and Stelljes, M. and Beelen, D. and Markiewicz, M. and Remenyi, P. and Dreger, P. and Ciceri, F. and Wagner-Drouet, E. M. and Junghanss, C. and Scheid, C. and Patriarca, F. and Socie, G. and Hilgendorf, I. and Rambaldi, A. and Schaefer-Eckart, K. and Russo, D. and Grigoleit, G. U. and Wulf, G. and Basara, N. and Glass, B. and Labussiere-Wallet, H. and Stuhler, G. and Bieniaszewska, M. and Casper, J. and Holler, Ernst and Benedetti, F. and Iori, A. P. and Trenschel, R. and Bethge, W. (2022) O044 GVHD and GFRS in patients with AML undergoing allogeneic transplantation with treosulfan- versus busulfan-based conditioning: a subgroup analysis of the randomized phase III MC-FludT.14/L trial. In: 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), March 19-23, 2022, Czech Republik.

Hilgendorf, I. and Mueller-Hilke, B. and Junghanss, C. and Leithaeuser, M. and Freund, M. and Wolff, D. (2009) Chronic GvHD is associated with a deficiency of CD27+IgD+IgM+ B cells. In: 35th Annual Meeting of the European Group for Blood and Marrow Transplantation, March 29-April 01, 2009, Göteborg, Sweden.

Wolff, D. and Herzberg, P. and Heussner, P. and Mumm, F. and Hilgendorf, I. and von Harsdorf, S. and Gerbitz, A. and Greinix, H. and Hildebrandt, G. and Junghanss, C. and Holler, E. (2009) Chronic GvHD of the lung significantly impairs quality of life and the activity profile - Results of a prospective German multicentre validation trial. In: 35th Annual Meeting of the European Group for Blood and Marrow Transplantation, March 29-April 01, 2009, Göteborg, Sweden.

Viehweg, M. and Herzberg, P. and Andree, H. and Hilgendorf, I. and Leithaeuser, M. and Junghanss, C. and Casper, J. and Freund, M. and Wolff, D. (2009) GvHD associated impairment of physical functioning, depression, and anxiety. Results from a prospective trial on physical and psychological functioning in patients before and after allogeneic haematopoietic stem cell transplantation. In: 35th Annual Meeting of the European Group for Blood and Marrow Transplantation, March 29-April 01, 2009, Göteborg, Sweden.

Kahl, C. and Wolff, D. and Nogai, A. and Kundt, G. and Hahn, J. and Holler, E. and Uharek, L. and Junghanss, C. and Leithaeuser, M. and Thiel, E. and Freund, M. (2009) Limited chronic GvHD significantly improves outcome after allogeneic haematopoietic stem cell transplantation in advanced haematological diseases. In: 35th Annual Meeting of the European Group for Blood and Marrow Transplantation, March 29-April 01, 2009, Göteborg, Sweden.

Other

Roellig, C. and Serve, H. and Huettmann, A. and Noppeney, R. and Mueller-Tidow, C. and Krug, U. and Baldus, C. D. and Brandts, C. H. and Kunzmann, V and Einsele, H. and Kraemer, A. and Schaefer-Eckart, K. and Neubauer, A. and Burchert, A. and Giagounidis, A. and Krause, S. W. and Mackensen, A. and Aulitzky, W. and Herbst, R. and Haenel, M. and Kiani, A. and Frickhofen, N. and Kullmer, J. and Kaiser, U. and Link, H. and Geer, T. and Reichle, A. and Junghanss, C. and Bornhaeuser, M. and Schaich, M. and Thiede, C. and Schetelig, J. and Kramer, M. and Berdel, W. E. and Ehninger, G. (2018) The addition of sorafenib to standard AML treatment results in a substantial reduction in relapse risk and improved survival. Updated results from long-term follow-up of the randomized-controlled SORAML trial. KARGER, BASEL.

Pfeifer, H. and Cayuela, J. -M. and Spiekermann, K. and Beck, J. and Jung, W. and Viardot, A. and Schaefer-Eckhart, K. and Reichle, A. and Maury, S. and Schmitz, N. and Heidenreich, D. and Panse, J. and Junghanss, C. and Raffoux, E. and Suarez, F. and Guillerm, G. and Alexis, M. and Lissandre, S. and Huguet, F. and Isnard, F. and Lepetre, S. and Escofffre-Barbe, M. and Ribera, J. -M. and Goekbuget, N. and Dombret, H. and Hoelzer, D. and Rousselot, P. and Ottmann, O. (2015) European working group for adult ALL phase II trial of nilotinib in combination with chemotherapy for first-line treatment in elderly patients with de novo Philadelphiachromosome positive acute lymphoblastic leukemia (EWALL-PH-02). KARGER, BASEL.

Pfeifer, H. and Rousselot, P. and Cayuela, J. M. and Karsten, S. and Beck, J. and Jung, W. E. and Viardot, A. and Schaefer-Eckart, K. and Reichle, A. and Maury, S. and Schmitz, N. and Heidenreich, D. and Panse, J. and Junghanss, C. and Raffoux, E. and Suarez, F. and Guillerm, G. and Alexis, M. and Lissandre, S. and Huguet, F. and Isnard, F. and Lepretre, S. and Escoffre-Barbe, M. and Ribera, J. M. and Goekbuget, N. and Hoelzer, D. and Dombret, H. and Ottmann, O. G. (2015) NILOTINIB IN COMBINATION WITH CHEMOTHERAPY FOR FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH PHILADELPHIA-POSITIVE ALL: RESULTS OF THE EUROPEAN WORKING GROUP FOR ADULT ALL(EWALL-PH-02). FERRATA STORTI FOUNDATION, PAVIA.